People

Celebrities and Royals from around the world. Right on schedule.

News

Daily news and events, covered by our international photographers.

Features

Odd, funny and touchy images. Be amazed.

Styling

Fashion and design trends.

Portrait

Premium Portraiture.

Reportage

In-depth Coverage.

Creative

Selected stock imagery.

Dukas Bildagentur
request@dukas.ch
+41 44 298 50 00

Your search:

47 result(s) in 0.07 s

  • MSD Office Entrance In Berlin
    DUKAS_187270407_NUR
    MSD Office Entrance In Berlin
    The logo and entrance of MSD (Merck Sharp & Dohme) are at the company's Berlin location in Berlin, Germany, on July 21, 2025. MSD is the international branch of American pharmaceutical giant Merck & Co., Inc., one of the world's largest biomedical companies by revenue. (Photo by Michael Nguyen/NurPhoto)

     

  • MSD Office Entrance In Berlin
    DUKAS_187270405_NUR
    MSD Office Entrance In Berlin
    The logo and entrance of MSD (Merck Sharp & Dohme) are at the company's Berlin location in Berlin, Germany, on July 21, 2025. MSD is the international branch of American pharmaceutical giant Merck & Co., Inc., one of the world's largest biomedical companies by revenue. (Photo by Michael Nguyen/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_186660882_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Alejandro Svarch Perez, Director General of IMSS-Bienestar, speaks during a news conference about how the government works to guarantee access to medicines, mainly generic medicines, which leads to a reduction in the price of patented medicines at the National Palace in Mexico City, Mexico, on July 4, 2025. (Photo by Carlos Santiago/ Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_186660853_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Alejandro Svarch Perez, Director General of IMSS-Bienestar, speaks during a news conference about how the government works to guarantee access to medicines, mainly generic medicines, which leads to a reduction in the price of patented medicines at the National Palace in Mexico City, Mexico, on July 4, 2025. (Photo by Carlos Santiago/ Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_186660805_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Alejandro Svarch Perez, Director General of IMSS-Bienestar, speaks during a news conference about how the government works to guarantee access to medicines, mainly generic medicines, which leads to a reduction in the price of patented medicines at the National Palace in Mexico City, Mexico, on July 4, 2025. (Photo by Carlos Santiago/ Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624930_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624928_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Economic Minister, Marcelo Ebrard Casaubon, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624923_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Health Minister, David Kershenobich Stalnikowitz, and Mexico's Economic Minister, Marcelo Ebrard Casaubon, attend the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624916_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's President Claudia Sheinbaum Pardo speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624915_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's President Claudia Sheinbaum Pardo, accompanied by Marcelo Ebrard, David Kershenobich Stalnikowitz, Diego Antonio Gutierrez de Velasco, Federico Prince Laris, Jose Miguel Ramos Rodriguez, Luz Astrea Ocampo Gutierrez de Velasco, and Efren Ocampo Lopez, poses for photos during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624914_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Economic Minister, Marcelo Ebrard Casaubon, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624904_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's President Claudia Sheinbaum Pardo speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624903_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's President Claudia Sheinbaum Pardo speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624902_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's President Claudia Sheinbaum Pardo speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624901_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's President Claudia Sheinbaum Pardo, accompanied by Marcelo Ebrard, David Kershenobich Stalnikowitz, Diego Antonio Gutierrez de Velasco, Federico Prince Laris, Jose Miguel Ramos Rodriguez, Luz Astrea Ocampo Gutierrez de Velasco, and Efren Ocampo Lopez, poses for photos during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624900_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Economic Minister, Marcelo Ebrard Casaubon, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624895_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Economic Minister, Marcelo Ebrard Casaubon, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624893_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Economic Minister, Marcelo Ebrard Casaubon, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624885_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's President Claudia Sheinbaum Pardo speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624883_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Economic Minister, Marcelo Ebrard Casaubon, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624881_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's President Claudia Sheinbaum Pardo speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624879_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Economic Minister, Marcelo Ebrard Casaubon, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624859_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Executive Chairman of the Board of Neolpharma Group, Diego Antonio Gutierrez de Velasco, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624858_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624952_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    The CEO of Neolpharma Group, Luz Astrea Ocampo Gutierrez de Velasco, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624943_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    The CEO of Kener Laboratories, Federico Prince Laris, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624941_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624940_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    The General Director of GENBIO, Jose Miguel Ramos Rodriguez, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624939_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    The CEO of Neolpharma Group, Luz Astrea Ocampo Gutierrez de Velasco, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624931_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma for the manufacturing of specialized medications in Mexico at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    DUKAS_186624929_NUR
    Mexico’s President Claudia Sheinbaum Presents Plan Mexico
    Mexico's President Claudia Sheinbaum Pardo speaks during the presentation of Plan Mexico to the national pharmaceutical industry with the companies Laboratorios Kener and Grupo Neolpharma at a news conference at the National Palace in Mexico City, Mexico, on July 3, 2025. (Photo by Luis Barron/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Health Finance
    DUKAS_186553784_NUR
    Health Finance
    The US dollars and some medicine finance health in the USA. (Photo by Bibek Raj Giri/NurPhoto)

     

  • Health Finance
    DUKAS_186553781_NUR
    Health Finance
    Australian dollars and some medicines represent health costs in Australia. (Photo by Bibek Raj Giri/NurPhoto)

     

  • Health Finance
    DUKAS_186553778_NUR
    Health Finance
    Hong Kong dollars and some medicine illustrate health costs in Hong Kong. (Photo by Bibek Raj Giri/NurPhoto)

     

  • Lenacapavir HIV Vaccine Photo Illustrations
    DUKAS_186209985_NUR
    Lenacapavir HIV Vaccine Photo Illustrations
    The 'lenacapavir' inscription displayed on a screen and illustrative syringes are seen in this illustration photo taken in Krakow, Poland on June 20, 2025. (Photo by Jakub Porzycki/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403376_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Eduardo Clark Garcia, Mexico's Health Undersecretary, speaks during a briefing conference about implementing an Executive Order to promote investment by the pharmaceutical and health care industry at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403373_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during a briefing conference about the creation of a biopharma ecosystem, which is reflected in the Mexico Plan for drug development at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/ Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403371_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during a briefing conference about the creation of a biopharma ecosystem, which is reflected in the Mexico Plan for drug development at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/ Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403368_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during a briefing conference about the creation of a biopharma ecosystem, which is reflected in the Mexico Plan for drug development at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/ Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403366_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Eduardo Clark Garcia, Mexico's Health Undersecretary, speaks during a briefing conference about implementing an Executive Order to promote investment by the pharmaceutical and health care industry at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403365_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Eduardo Clark Garcia, Mexico's Health Undersecretary, speaks during a briefing conference about implementing an Executive Order to promote investment by the pharmaceutical and health care industry at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403362_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Eduardo Clark Garcia, Mexico's Health Undersecretary, speaks during a briefing conference about implementing an Executive Order to promote investment by the pharmaceutical and health care industry at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403361_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during a briefing conference about the creation of a biopharma ecosystem, which is reflected in the Mexico Plan for drug development at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/ Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403359_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during a briefing conference about the creation of a biopharma ecosystem, which is reflected in the Mexico Plan for drug development at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/ Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403355_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Eduardo Clark Garcia, Mexico's Health Undersecretary, speaks during a briefing conference about implementing an Executive Order to promote investment by the pharmaceutical and health care industry at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403349_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during a briefing conference about the creation of a biopharma ecosystem, which is reflected in the Mexico Plan for drug development at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/ Eyepix Group) (Photo by Eyepix/NurPhoto)

     

  • Mexico’s President Claudia Sheinbaum Holds Briefing
    DUKAS_185403415_NUR
    Mexico’s President Claudia Sheinbaum Holds Briefing
    Mexico's Health Minister, David Kershenobich Stalnikowitz, speaks during a briefing conference about the creation of a biopharma ecosystem, which is reflected in the Mexico Plan for drug development at the National Palace in Mexico City, Mexico, on May 29, 2025. (Photo by Carlos Santiago/ Eyepix Group) (Photo by Eyepix/NurPhoto)